Business News
RFK Jr. could take aim at the food industry with coming dietary guidelinesHHS Secretary Kennedy says updated dietary guidelines will prioritize public health over special interests
Updated April 4, 20252 min read
HHS Secretary Kennedy says updated dietary guidelines will prioritize public health over special interests
Plus: three ways Big Tech is vulnerable to tariff retaliation
Plus: three ways Big Tech is vulnerable to tariff retaliation
Plus: three ways Big Tech is vulnerable to tariff retaliation
New auto tariffs begin Thursday, prompting swift reactions from automakers
U.S. brands face rising costs and potential price hikes as major suppliers — China and Vietnam — face steep levies
The digital healthcare platform announced Tuesday that it has added Zepbound and generic liraglutide to its platform
Investors are keeping a close eye on Trump’s unveiling of reciprocal tariffs — and what they could mean for the global economy
Novo Holdings reached record earnings in 2024 as sales of Novo Nordisk's blockbuster weight loss drug continue to soar
Plus: Chipotle’s avocado hunt
Plus: Chipotle’s avocado hunt
Plus: Chipotle’s avocado hunt
Research shows a dramatic increase in GLP-1 prescriptions among people without diabetes; spending hit nearly $6 billion in 2022
The pharma giant just sued two compounding pharmacies for making off-brand versions of Zepbound
The state-owned brain chip company plans to implant its experimental device on at least 13 patients by the end of the year
The streaming service is "the new king of all media," according to MoffettNathason
The pharma giants shared new clinical trial results, highlighting potential heart benefits of their meds
Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, resigned last week
Plus: Bill Gates says a 2-day work week is on the way
Plus: Bill Gates says a 2-day work week is on the way
Plus: Bill Gates says a 2-day work week is on the way
Eli Lilly plans to appeal the decision, while the drug remains approved in the U.S. and other markets
Plus, Eli Lilly's direct-to-consumer online platform now offers Alzheimer's resources and Wegovy sales take a hit from copycat competition
Novo Nordisk chief Lars Fruergaard Jørgensen told investors that compounded drugs impacted its prescription uptake in early 2025